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Abstract
Background: Exposure to intermittent hypoxia (IH) may enhance cardiac function and protects heart against
ischemia-reperfusion (I/R) injury. To elucidate the underlying mechanisms, we developed a cardioprotective IH model
that was characterized at hemodynamic, biochemical and molecular levels.
Methods: Mice were exposed to 4 daily IH cycles (each composed of 2-min at 6-8% O2 followed by 3-min
reoxygenation for 5 times) for 14 days, with normoxic mice as controls. Mice were then anesthetized and subdivided
in various subgroups for analysis of contractility (pressure-volume loop), morphology, biochemistry or resistance to
I/R (30-min occlusion of the left anterior descending coronary artery (LAD) followed by reperfusion and measurement
of the area at risk and infarct size). In some mice, the phosphatidylinositide 3-kinase (PI3K) inhibitor wortmannin was
administered (24 µg/kg ip) 15 min before LAD.
Results: We found that IH did not induce myocardial hypertrophy; rather both contractility and cardiac function
improved with greater number of capillaries per unit volume and greater expression of VEGF-R2, but not of VEGF.
Besides increasing the phosphorylation of protein kinase B (Akt) and the endothelial isoform of NO synthase with
respect to control, IH reduced the infarct size and post-LAD proteins carbonylation, index of oxidative damage.
Administration of wortmannin reduced the level of Akt phosphorylation and worsened the infarct size.
Conclusion: We conclude that the PI3K/Akt pathway is crucial for IH-induced cardioprotection and may represent a
viable target to reduce myocardial I/R injury.
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Introduction
Ischemic preconditioning (IP), term used to identify the
phenomenon whereby repeated exposures to sub-lethal
ischemia episodes enhance myocardial protection against
potentially lethal ischemia [1], probably still represents the best
tool for efficient prevention strategy against cardiovascular
diseases. IP is composed of an immediate (hours) and a
delayed (days) phase [2]. Whereas the first is caused by rapid
posttranslational modification of existing proteins, the latter,
also called “second window of protection” or SWOP, provides
sustained protection as a result of persisting changes in the
expression of proteins involved in protection [3]. Although IP is
a potentially powerful and economic approach to reduce the
burden of myocardial ischemia disease, several bottlenecks
prevent its usability in humans. Exercise training is
nevertheless a recognized strategy to induce delayed IP [4].
However, recommending exercise training is not a feasible
option for some patients, including individuals with physical
disabilities or exercise-intolerant patients, who may therefore
be considered at high risk for cardiovascular diseases.
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Alternative non-invasive techniques to induce IP are therefore
envisaged.
A procedure that is gaining popularity among athletes
because of promising results in terms of fitness and endurance
gain, intermittent hypoxia (IH) is currently under scrutiny for
prevention of cardiovascular diseases as well. IH was shown to
increase exercise tolerance in elderly men with and without
coronary artery disease [5] and to improve myocardial
perfusion in coronary patients [6]. However the underlying
mechanisms, which may be responsible for the marked
dichotomy in the effects of IH on the cardiovascular system,
remain elusive: besides representing a cardioprotective
paradigm, IH is also associated to overt myocardial damage in
patients suffering from obstructive sleep apnea (OSA). The
protective vs. damaging effects of IH were examined elsewhere
[7]: possibly the three-phase time-dependent effect modulated
by GATA-4-dependent gene transcriptional regulation via
inhibition of histone deacetylase play an important role [8]. But
the characterization of the transformation of IH from a
cardioprotective into an adverse factor is beyond the purposes
of the present study, which mainly focuses into the
cardioprotective effects of IH.
Protein kinase B, or Akt, plays an important role in the
phosphatidylinositide 3-kinase (PI3K) signaling pathway. When
activated through translocation to the membrane and
phosphorylation on either Thr-308 or Ser-473, Akt stimulates a
variety of targets and acts as a nodal regulatory kinase in
myocardium [9], mainly with pro-survival, proliferative and
protective effects. The purpose of this study is to develop a
cardioprotective IH model to identify the underlying
mechanisms at morphological, biochemical and molecular
levels.
To address cardioprotection, we adopted a validated method
[10]. Angiogenesis was addressed by measuring the vascular
endothelial growth factors (VEGFs), a family of glycoproteins
involved in the regulation of vasculogenesis. The hypoxia-
inducible factor (HIF)-1α stimulates VEGF expression by direct
transcriptional activation and through the PI3K/Akt signaling
pathway [11]. VEGF binds to tyrosine kinase receptors (VEGF-
Rs), one of which, VEGF-R2/flk-1, whose synthesis occurs
through an autocrine mechanism [12], is known to mediate the
majority of the cell responses to VEGF-A, the most important
VEGF isoform. To address the effects of IH on the oxidative
stress, we measured the expression of the inducible isoform of
the major heat shock protein, HSP70, due to its known
protective role during acute hypobaric hypoxia [13] and
exercise training [14]. Wortmannin, a fungal metabolite that
irreversibly binds and inhibits mammalian PI3K with an IC50 in
the low nanomolar range, thereby preventing Akt
phosphorylation [15], provides a unique way to test the
involvement of the PI3K signaling pathway in this situation.
Materials and Methods
Animal experiments were performed in accordance with the
Swiss federal law and with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996). The protocol
was approved by the Committee of the Ethics of Animal
Experiments of the Centre Hospitalier Universitaire Vaudoise
(Permit Number 2262). All surgery was performed under
ketamine-xylazine anesthesia and all efforts were made to
minimize suffering.
Experiments were conducted on 8-10-wk old male C57Bl6
mice (Charles River, France). Mice were fed standard diet
without limitations until 24 h before sacrifice. Room
temperature was kept at 21±2°C and 12 h of light were
alternated to 12 h of dark.
Intermittent hypoxia protocol
Mice were placed in gas-tight Plexiglas boxes (40x20x20 cm)
equipped with a Clark-type O2 electrode and flushed with room
air by means of a gas pump. A system of computer-assisted
solenoid valves was operated to distribute air or N2 to the
chamber. At the beginning of the IH events, the chambers were
flushed with N2 for 3 min to achieve 6-8% O2 followed by 2 min
air to restore 21% O2. Each cycle was repeated 5 times and
each IH train was applied 4 times/day for 14 days (5 h 35 min
between two successive IH trains, Figure 1). A total of 32 mice
were exposed to IH, while 40 were maintained in control
conditions (air in the place of N2). Three hours after the last IH
train, mice were anesthetized by intraperitoneal injection of
ketamine (150 mg/kg) plus xylazine (5 mg/kg), and randomly
assigned to a group of tests. In additional control or IH mice
(10/10), the PI3K inhibitor wortmannin was administered
intraperitoneal (24 µg/kg) 15 min before ischemia.
Left ventricular Pressure-Volume (P-V) loops analyses
Hemodynamic parameters were collected in 7/6 control/IH
mice. The anesthetized mouse was placed in a supine position
on a heating pad at 37.5°C. The trachea was cannulated and
the animal attached to a positive-pressure volume controlled
rodent ventilator (MiniVent, Hugo Sachs Elektronik, Harvard
Apparatus, March-Hugstetten, Germany). The tidal volume and
the ventilatory rate were set at 200-250 µl and 110-130
breaths/min, respectively. The right carotid artery was
dissected and a Millar Mikro-Tip conductance catheter (model
SPR-839, tip size of 1.4F, Millar Instruments, Oxford, UK)
introduced into the artery and advanced into the LV via the
aortic valve [16]. Once steady-state hemodynamic was
achieved, P-V loops were recorded and processed using an
MPVS Ultra system (Millar Instruments, Oxford, UK). The
cuvette calibration method (Millar Instruments) was used to
calculate the absolute volume data.
LAD ligature
Myocardial infarction was induced by regional left anterior
descending (LAD) coronary artery occlusion in 15/12 control/IH
mice (5/5 of these were administered with wortmannin). After
anesthesia, the trachea was cannulated and mice ventilated as
described above. A left thoracotomy was performed between
the 4th and 5th rib and the heart was exposed to pass a 7-0
silk at 2-mm below the tip of the left auricle. The suture was
tied using a shoestring knot over a 1-mm polyethylene tube
(PE-10). After 30 min ischemia [17], the LAD was reopened for
3 h by pulling on the exteriorized suture to release the knot and
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the heart reperfused. Of all hearts subjected to this procedure,
8/5 control/IH hearts were used for the measurement of
proteins carbonyl groups (see below), whereas 10/7 hearts
were used to measure the area at risk and the infarct size.
Area at risk and infarct size
At the end of the reperfusion, the LAD was re-occluded and
5% Evans blue (250 µl) was injected into the left ventricle to
mark the ischemic zone as tissue area without the blue dye.
The heart was frozen in liquid N2 and stored at -20°C until
analysis. To measure the infarct and risk areas, the heart was
cut into five/six 1-mm thick transverse slices from apex to base.
The slices were incubated in 1% triphenyltetrazolium chloride
in sodium phosphate buffer at 37°C for 20 min to stain viable
cells in the risk zone. Afterwards, the slices were immersed in
10% formalin for 24 h to enhance contrast between stained and
unstained areas, with the latter representing the infarct size.
The extent of stained and unstained areas was calculated for
each slice from computerized images using NIH Image
software. The risk area is expressed as percentage of total
ventricle area whereas the infarct area is expressed as a
percentage of the risk area.
Myocardial morphology
For morphologic measurements in 4/4 control/IH freshly
removed hearts, excess water was absorbed on paper, atria
were excised and the ventricles plus the septum were weighed
using a precision balance. In additional 5/4 control/IH mice,
small fragments (<1 mm3) of the left ventricle tip were quickly
fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, post-
fixed with 1% OsO4 in the same buffer, dehydrated with
alcohol, and embedded in araldite. Semi-thin sections stained
with 1% toluidine blue in distilled water at 60°C, were used to
evaluate the number of capillaries/mm2. For each heart,
seventy-five non-overlapping areas (800x magnification) were
digitalized and analyzed making use of the Olympus BX51
microscope with the Olympus C-3030 digital camera and the
Cell^B software. The total surface evaluated per condition was
1.44 mm2. The number of capillaries was evaluated following
the visual identification of endothelial cells, as previously
described [18]. Thin sections, stained with uranyl acetate and
lead citrate, were observed with a transmission electron
microscope (Philips CM10).
Figure 1.  Scheme of the intermittent hypoxia protocol used in this study.  FIO2: fraction of O2 in inspired air (%).
doi: 10.1371/journal.pone.0076659.g001
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Myocardial tissue analyses
In 6/6 control/IH mice, freshly removed hearts were quickly
rinsed in ice-cold PBS (pH 7.4), clamped between steel tongs
pre-cooled with liquid N2 and stored at -80°C until analysis. For
Akt assays, we also evaluated 5/5 control/IH mice treated with
wortmannin.
Western blot
The expression level of target proteins was analyzed by
Western blot technique. Frozen left ventricles were lysed in a
buffer containing 10 mM TRIS-HCl, 50 mM KCl, 1 mM EDTA,
1% NONIDET P-40 and 3% Protease Inhibitor Cocktail (Sigma,
St. Louis, MO, USA). Protein concentration was measured
using either the Protein Assay or the Coomassie Blue kit (Bio-
Rad Laboratories, Hercules, CA) according to manufacturer’s
instructions. Equal amount of protein (40 µl) were separated on
SDS-PAGE gel, electroblotted onto nitrocellulose membranes
(Bio-Rad Laboratories, Hercules, CA). After blocking in Tris-
Buffered Saline (TBS) containing 0.1% Tween-20 (TBS-T) and
5% of non-fat milk for 1 h at room temperature, membranes
were probed overnight at 4°C with the following primary
antibodies: rabbit polyclonal anti-VEGF-A (Calbiochem,
Nottingham, UK); rabbit monoclonal anti-VEGF-R2 (Cell
Signaling Technology, Danvers, MA); mouse monoclonal anti-
α-actinin (Sigma, St. Louis, MO, USA); rabbit anti-α-tubulin
(Santa Cruz Biothechnology); anti-Grp94 (clone 3C4 [19]); anti-
Hsp70 (SPA-810, Stressgen); anti-HO-1 (OSA-110;
Stressgen); anti-eNOS and P-eNOS (Ser1177) (Santa Cruz
Biotechnology); anti-Akt and P-Akt Ser473 (Cell Signaling
Technologies Abs); rabbit anti HIF-1α (Santa Cruz
Biotechnology); and rabbit anti-Nrf2 (Santa Cruz
Biotechnology). After washing three times with TBS-T,
secondary antibodies were goat anti-mouse or goat anti-rabbit
IgG (H+L) (Pierce, Rockford, IL), conjugated to horseradish
peroxidase for 1 h at room temperature. Horseradish
peroxidase reaction was detected using an enhanced
chemiluminescent substrate, Super Signal West Dura
Extended Duration (Pierce, Rockford, IL). Bands were scanned
and their density quantified by means of BioRad GelDoc 2000
with reference to α-actinin or α- tubulin as loading controls.
CHOP immunolocalization
Double immunofluorescence was performed to visualize
translocation of the CHOP transcription factor into
cardiomyocyte nuclei. After fixation and permeabilization as
described [19], cryosections were incubated for 1 h at room
temperature with a mixture of rabbit polyclonal anti-CHOP
antibodies (R-20 or F-168, Santa Cruz Biotech) and mouse
monoclonal anti-α sarcoglycan antibody (Monosan) to decorate
cardiomyocyte sarcolemma. After adequate rinses, sections
were incubated overnight at 4C with species-specific
fluorescein and Texas Red conjugated secondary antibodies
obtained in goat (Santa Cruz Biotech) and centrifuged before
use to eliminate aggregates. Section were rinsed, mounted
with buffered glycerol containing 4 µg/ml DAPI and observed
using the Zeiss Microscope Axioplan equipped with
epifluorescence optics. Images were acquired using a Leica
digital DFC 300FX camera and the IM50 software (Leica
Microsystems SRL, Milano, Italy). Three to four micrographic
fields were collected consistently from sub-endocardial and
sub-epicardial regions of each sample in order to evaluate at
least 300 cardiomyocyte nuclei per section.
Protein carbonyl groups
In 8/5 control/IH mice we measured the amount of protein
carbonyl groups. This analysis was also performed in 8/5
control/IH mice after LAD ligature and reperfusion. Pre- and
post-LAD hearts were frozen in liquid N2 and protein
carbonylation analyzed using the OxyBlot protein oxidation
detection kit (Millipore) as previously described [20]. In brief,
about 10 sections (12 µm thickness) were cut transversally
from the left ventricle wall. About 12 µg protein was used for
derivatization with DNPH. The degree of protein carbonylation
was determined after normalization with the amount of loaded
proteins, evaluated by densitometry of the Ponceau Red
staining.
Statistics
Data are expressed as mean±SEM. Significance level was
P=0.05 (two-tailed). To detect differences among the groups,
we routinely perform one-way ANOVA followed by the
Neuman-Keuls post-test. When two groups are compared, this
test reduces to the Student’s t-test.
Results
Intermittent hypoxia improves myocardial contractility
IH mice showed a modest albeit significant decrease in body
weight compared to control (Table 1). As heart weight also
decreased in IH, the heart/body weight ratio was the same in
the two groups, indicating lack of cardiac hypertrophy.
Hematological parameters were maintained in all groups (not
shown). Hemodynamic data and the pressure-volume loop
curves measured in control and intermittent anesthetized mice
(Figure 2) show that exposure to IH did not affect neither the
end-systolic nor the end-diastolic volumes. Likewise, the end-
diastolic pressure was only marginally reduced by IH with a
significant increase in end-systolic pressure respect to control.
IH also induced a significant increase and decrease in
maximum and minimum derivative pressures, respectively,
compared to control. As a final result, the cardiac output
increased from 2437, SE 233 to 3345, SE 528 µl/min (P=0.03),
e.g. a 27% increase, indicative of markedly improved
myocardial performance as an outcome of the IH treatment.
Intermittent hypoxia induces neo-angiogenesis through
VEGF-R2 signaling
Toluidine-blue staining shows a marked increase in the
number of endothelial cells per unit area in IH with respect to
control (Figure 3A), indicative of neo-angiogenesis. The
average capillary count per unit area increased markedly in left
ventricles from IH mice with respect to control (P=0.03, Figure
3B-C). Likewise, the expression of the vascular endothelial
growth factor (VEGF) receptor 2 (VEGF-R2, also known as
KDR/Flk-1) was increased in IH vs. control hearts (P=0.009).
Cardioprotection Induced by Intermittent Hypoxia
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Table 1. Animal data and characteristics (mean±SE).
 Control Intermittent hypoxia
 Mean SE n Mean SE n
Body weight       
initial, g 21.52 0.25 50 21.48 0.20 42
final, g 22.50 0.31 50 20.30 0.39* 42
change, g 0.98 0.21 50 -0.39 0.14* 42
Heart       
Heart weight, mg 98.1 4.1 7 87.0 1.2* 6
Heart/body weight, mg/g 4.50 0.12 7 4.23 0.08 6
*, p<0.05 (Student’s t-test).
doi: 10.1371/journal.pone.0076659.t001
Whereas the protein expression of 42 kDa isoform of VEGF
(VEGF42, i.e., the soluble fraction) was unaffected by IH, the
55 kDa isoform (VEGF55, i.e., the membrane-bound fraction)
was slightly over-expressed, but without statistical significance
(P=0.07, Figure 3B-C). Transmission electron microscopy
(Figure 3D-E) further supports increased capillary count in IH
hearts. The progressive appearance of a cellular “bridge” is
visible: pericytes appear to be involved in the formation of an
intercapillary pillar. Junctional complexes are formed between
opposite pericyte walls. In panel E, pillar size is similar to that
in D. The merging of the lateral walls has completed the
“bridge” structure.
Figure 2.  Hemodynamic data.  Panel A. Pressure-volume loops obtained in ten consecutive contractions in two representative
mice from either group. Panel B. Some hemodynamic data (mean±SEM) obtained in all the examined mice (n=7/6 control and
intermittent hypoxia, respectively), * marks P<0.05 with respect to control, Student’s two-tailed t-test. The diastolic (clear) and
systolic (shaded) volumes, systolic (clear) and diastolic (shaded) pressures, +dP/dtmax (shaded) and -dP/dtmax (clear), and the
cardiac output (clear) are reported.
doi: 10.1371/journal.pone.0076659.g002
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Intermittent hypoxia slightly enhances the oxidative
stress
IH increased the protein expression of heme oxygenase-1
(HO-1, Figure 4A, C). This increase was blunted in mice
treated with wortmannin, in analogy with the effect led by this
PI3K inhibitor on Akt phosphorylation (see later). By contrast,
the expression level of Heat Shock Protein 70 kDa (HSP-70)
and glucose-regulated protein 94 (GRP94), stress-proteins that
were demonstrated to be up-regulated by hypoxia [21,22],
remained unchanged. The pro-apoptotic factor endoplasmic
reticulum stress-induced transcription factor C/EBP
homologous protein (CHOP) was decreased by IH, without any
effect led by wortmannin.
To assess whether HO-1 expression was increased
consequently to an endoplasmic reticulum-stress response, a
double immunofluorescence analysis was performed to
investigate the nuclear localization of the transcription factor
CHOP (Figure 4B). In control hearts, about half of
cardiomyocyte nuclei, identified by means of a nuclear
fluorescent stain and circumscribed by α-sarcoglycan-positive
sarcolemma, showed positive labeling for CHOP. This number
appeared reduced in IH. To quantitatively assess this
Figure 3.  Angiogenesis. Panel A. Representative semithin sections stained with toluidine-blue from the left ventricle of a
control and an IH mouse.  The arrows indicate endothelial cells. The horizontal bar represents 10 µm. Panel B. Representative
Western blots reporting the protein expression of VEGF-R2, VEGF55, VEGF42 as well as α-actinin (loading control). Panel C. Data
related to angiogenesis as obtained in all available hearts (mean±SEM, n=6/6 control and intermittent hypoxia, respectively), *
marks P<0.05 with respect to control, Student’s two-tailed t-test. The capillary count per unit area, as well as the expression of
VEGF-R2, VEGF isoforms VEGF42 and VEGF55 as normalized for α-actinin (Western blot) are reported. Panels D and E.
Transmission electron microscopy images of left ventricle sections from an IH mouse. In panel C, arrows (→) indicate endothelial
junctions. In panel D, arrow heads (►) show a cellular “bridge” that partitions a pre-existing capillary in the process of neo-
angiogenesis. Ca, capillary lumen; Ec, erythrocytes; Ej, endothelial junctional complexes; Pc, pericyte. The horizontal bar
represents 0.25 µm.
doi: 10.1371/journal.pone.0076659.g003
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reduction, we considered 300 cardiomyocyte nuclei per heart in
5/5 control/IH hearts and measured the percentage of nuclei
showing CHOP labeling (49.16±4.04%, and 38.00±2.00%,
respectively, P=0.03). Thus cardiomyocyte nuclei with CHOP
labeling were reduced by about one-third in IH. In mice treated
with wortmannin, the percentage of nuclei showing CHOP
labeling changed to 51.75±5.19%, and 35.33±4.07%,
respectively (P=NS from non-treated mice), showing that the
pattern was not affected by wortmannin (microphotographs not
shown).
Figure 4.  Stress proteins.  Panel A. Sample Western blot images illustrating the protein expressions of HO-1, HSP70, GRP94
(referred to α-actin). Panel B. Double immunofluorescence analysis to investigate the nuclear localization of the transcription factor
CHOP. The left column shows representative staining using anti-CHOP antibodies (red fluorescence), whereas the middle column
shows α−sarcoglycan antibodies (green fluorescence). Nuclei were counterstained with DAPI (blue fluorescence). Arrows indicate
cardiomyocyte nuclei positive for CHOP staining, which appears pink when merged with DAPI (right column). The upper and lower
rows report a sample control and intermittent hypoxia heart. Bar: 50 µm. Panel C. Quantification of stress proteins from
densitometry analysis of Western blots and analysis of Panel B images in all available samples (mean±SEM, n=6/6). *, P<0.05 with
respect to control, Student’s two-tailed t-test. This panel also shows the effect of wortmannin on the expression of HO-1 and CHOP
(n=5/5).
doi: 10.1371/journal.pone.0076659.g004
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Intermittent hypoxia potentiates PI3K-Akt signaling
Whereas the expression of Akt was not affected by IH, P-Akt
expression was roughly 2.5 times higher in IH hearts (Figure
5). The inhibitor wortmannin markedly reduced the expression
of Akt and its phosphorylation in both control and IH hearts.
The phosphorylation of the endothelial isoform of NO synthase
(eNOS, or NOS3) is known to depend on the activity of Akt. In
support of this, P-eNOS was markedly increased in IH but
maintained in control hearts, whereas treatment with
wortmannin blunted both eNOS expression and
phosphorylation. The hypoxia-signaling path did not appear
prominent and the expression level of HIF-1α was unchanged
in control and IH hearts, and the treatment with wortmannin did
not affect its expression. By contrast, IH increased the
expression of the oxidative stress transducer nuclear factor
(erythroid-derived 2)-like 2 (Nrf2), and the treatment with
wortmannin greatly reduced Nrf2 expression both in control
and IH hearts.
Intermittent hypoxia-induced cardioprotection depends
on Akt
Figure 6A shows representative images taken in one control
and one IH heart after staining myocardial tissues slices with
triphenyltetrazolium chloride to mark the infarct and risk areas.
Whereas the blue and white areas represent viable and
necrotic tissues, respectively, the red+white area represents
the area at risk. Figure 6B shows the averaged risk and infarct
areas of all the hearts subjected to LAD occlusion and
reperfusion. Both IH and wortmannin did not change the risk
zone, indicating that the extent of the LAD ligature was the
same in all the groups. However, the infarct area was markedly
decreased in IH, indicating the occurrence of IH-induced
cardioprotection. The presence of wortmannin, on the other
hand, blunted the protective effect of IH.
Cardioprotection was also evaluated by assessing the
degree of protein carbonylation, an index of redox unbalance
(Figure 6C). Normalized densitometry values (Oxy/RP)
increased markedly in myocardial tissue of control hearts
compared to IH, reflecting the occurrence of oxidative stress in
control but not in IH (P<0.01) (Figure 6D).
Discussion
The IH protocol described here enabled hearts to improve
performance, induce neo-angiogenesis, increase the
expression of HO-1 and decrease that of CHOP, indicative of
attenuated apoptosis induced by endoplasmic reticulum stress.
By contrast, the myocardial diastolic function and the
expression levels of HSP70 and GRP94 were not affected by
IH, indicative of lack of major adverse events originated by
excess oxidative stress. Likewise, the hypoxia signaling
pathway did not appear to be altered by IH, as indicated by
lack of changes in HIF-1α. Nevertheless, Akt phosphorylation
was markedly increased. Collectively, these effects led to two
important hallmarks in cardiovascular protection. First, cardiac
function was improved, in qualitative agreement with data
obtained in healthy and transgenic (over-expression of tumor
necrosis factor α, which induces heart failure) rodent models
[23]. Second, cardioprotection was ameliorated as from
reduced infarct size after LAD ligature and reduced formation
of protein carbonyl groups in response to LAD. The
administration of the PI3K inhibitor wortmannin suppressed Akt
phosphorylation and some of the downstream effects, including
eNOS and Nrf2, leaving HIF-1α unaffected. The inhibition led
by wortmannin on Nrf2 expression, and hence the link between
PI3K activity and the regulation of anti-oxidative proteins, has
already been demonstrated [24]. Furthermore, wortmannin
reversed the favorable effects led by IH in terms of infarct size
reduction, indicating that the cardioprotection induced by IH
appeared directly related to the IH-induced over-
phosphorylation of Akt.
The measurement of the infarct area following LAD
occlusion/reperfusion is related to the functional recovery of
Langendorff-perfused hearts after I/R [10]. The LAD occlusion
challenged ≈40% of the left ventricle in all groups, yet the infarct
area at the end of the reperfusion was 50% of the risk area in
control hearts, which reduced by half in IH hearts, as a result of
effective cardioprotection. IH-induced cardioprotection was
entirely reverted by previous administration of wortmannin. This
outcome is in qualitative agreement with a study where IH was
given by exposing rats to a single 4-h period of hypobaric
hypoxia (barometric pressure=404 mmHg) each day for four
weeks [25]. At odds with the present investigation, in that study
rats did not experience any significant change in body mass
nor improved baseline myocardial performance. Whereas
those Authors focused into the post-conditioning-like effects led
by IH addressing the role of mitochondria in generating sub-
lethal doses of ROS early at the reperfusion after ischemia in
Langendorff-perfused hearts [26], here we focus into the pre-
conditioning effects of IH by addressing the role of a number of
signaling pathways.
IH and angiogenesis
Administering IH for 14 days markedly increased the
capillary network. Electron microscopy demonstrated the
formation of intercapillary pillars, which supports the hypothesis
that neo-angiogenesis occurred mostly by intussusceptive
growth, also known as splitting angiogenesis. This modality of
capillary growth is characterized by capillary bed expansion
through formation of finger-like inter-endothelial protrusions,
which give rise to transcapillary tissue pillars forming a
transluminar bridge, and eventually generate new vascular
segments [27]. The intussusceptive angiogenesis, typical of
developmental processes, generally coexists with vascular
sprouting, the alternative modality of angiogenesis which
predominates in cancer tissues [28]. Notably, intussusceptive
capillary growth is fast (minutes-hours) as it does not primarily
need cell proliferation. It is believed that an extended capillary
network increases the blood supply and provides alternative
shunt circulation on vessel obstruction, thus contributing to
cardioprotection. In the described IH frame, neo-angiogenesis
was accompanied by increased VEGF-R2 protein expression,
whereas VEGF proteins increase was of borderline statistical
significance, in analogy with observations gathered in aerobic
exercise-trained rats [18]. VEGF-A, perhaps the most important
VEGF isoform because of its critical role in the development of
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embryonic vasculature, binds to either one of the VEGF-R
isoforms, but the VEGF-R2/flk-1 isoform is known to mediate
the majority of cell responses to VEGF-A [29]. VEGF-A binding
causes VEGF-R2 dimerization and activation through a
Figure 5.  Signaling. Western blots of Akt, its phosphorylated isoform P-Akt, eNOS, its phosphorylated isoform P-eNOS,
HIF-1α and Nrf2 in all available samples (mean±SEM, n=6/6 and 5/5 without and with wortmannin, respectively).  *, P<0.05
with respect to control, Student’s two-tailed t-test.
doi: 10.1371/journal.pone.0076659.g005
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pathway leading to PLC-γ activation, increase in cytoplasm Ca+
+, activation of protein kinase C and phosphorylation of at least
two of the mitogen-activated protein kinases, e.g., extracellular
signal-regulated kinases ERK1/2 and p38 [30], which then
move to the nucleus where they participate to various
transcriptional activities leading to cell proliferation and
migration [31]. Of interest, an OSA-like IH paradigm increases
VEGF immunoreactivity in the carotid body thereby enhancing
carotid body chemosensory response to hypoxia [32].
VEGF and VEGF-R2 are known downstream effectors of the
hypoxia-inducible factor (HIF)-1α, the master regulator of O2
homeostasis. Although it is likely that the over-expression of
pro-angiogenesis factors depend on the myocardium response
to hypoxia, we were unable to document significant changes in
HIF-1α protein expression, perhaps due to the short hypoxia
times followed by reoxygenation, which blunts HIF-1α protein
over-expression [33]. We can’t exclude, however, the
occurrence of fast peaks in HIF-1α protein levels in the
correspondence of the hypoxia bouts. Indeed HIF-1α is likely to
play a critical role, because acute IH (6 min 6% O2 + 6 min 21%
O2, 5 times) gave protection that was lost in Hif1α+/- mice [34].
Albeit short, HIF-1α transactivation may nevertheless activate
the transcription of a number of growth factors related to
angiogenesis, including VEGF and its receptors. In mice
constitutively expressing HIF-1α, neo-angiogenesis is pivotal to
reduce infarct size and attenuate cardiac dysfunction through
VEGF-A protein expression in infarct and peri-infarct areas
[35]. As a matter of fact, however, the role of HIF-1α appeared
marginal in this study, because treatment of wortmannin
suppressed the cardioprotective role of IH leaving HIF-1α
unaffected.
IH mice are exposed not only to short hypoxic events, but
also to repetitive ROS bursts during the reoxygenation phase.
Such bursts might up-regulate HIF-1α activity. For example,
ROS activate PLC-γ signaling, thus increasing intracellular Ca++
and activating Ca++/calmodulin-dependent protein kinase
(CaMK), which phosphorylates the HIF-1α co-activator p300
and promotes HIF-1α activation [36]. Moreover, CaMK and
Figure 6.  Cardioprotection. Panel A. Representative images taken in a control and a IH heart after staining myocardial
tissues slices with triphenyltetrazolium chloride to mark the infarct and risk areas.  Whereas the blue and white areas
represent viable and necrotic tissues, respectively, the red+white area represents the area at risk. Panel B. Box-and-whisker plots
from all the hearts subjected to LAD occlusion and reperfusion. The boxes represent the 2nd and 3rd quartiles of data, with the
whisker delimiting the min-max range. The “+” represents the mean (n=10/7 and 5/5 without and with wortmannin, respectively). The
insets report the ANOVA values. Panel C. Left: Representative Oxyblot (Oxy) analysis. Right: Loading of the same nitrocellulose
sheet as visualized by Red Ponceau (RP) staining. Panel D. Normalized densitometry values (Oxy/RP), index of protein
carbonylation. *, P<0.05 with respect to control; $, P<0.05 with respect to PRE-LAD (ANOVA one-way test, followed by the
Bonferroni multiple comparison procedure, two tailed, the inset reports the value of the ANOVA P, n=6/6 and 8/5, pre-LAD and post-
LAD, respectively).
doi: 10.1371/journal.pone.0076659.g006
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diacylglycerol induce the activity of PKC, which stimulates
mTOR-dependent HIF-1α synthesis and inhibits its targeting to
ubiquitin by inhibiting prolyl-hydroxylases [37]. Since the
protection occurred after factors such as HIF-1α have
presumably returned to baseline, protection is likely related
more to morphological or persisting changes such as
angiogenesis than to direct effects by HIF-1α. Although the role
of neo-angiogenesis in promoting cardioprotection is
unquestionable, there is however evidence that other signaling
pathways may have a pivotal role in IH-induced
cardioprotection.
IH and stress response
The employed IH protocol is effective in increasing the
expression of HO-1, a HIF-1α target [38]. However, IH does not
affect the expression of the stress-proteins involved in the heat
shock pathway or the ER-stress response, as demonstrated by
lack of change in the amount of Hsp70 and Grp94. By contrast,
IH reduces the expression of CHOP and increases that of Nrf2,
a transcription factor that represents the primary defense
against the cytotoxic effects of oxidative stress and increases
the expression of several antioxidant enzymes. Furthermore,
IH appeared to decrease CHOP in about half of
cardiomyocytes. Although CHOP mRNA is not changed in
hearts exposed to 5 h hypoxia (10 or 6.5% O2) [39], these
findings might be explained with the evidence that CHOP
expression and activation are selectively blunted after inhibition
of prolyl-hydroxylases [40]. Prolyl-hydroxylases are inhibited by
hypoxia and their inhibition increases the transcription factor
Nrf2 [40], another positive regulator of HO-1 expression [38].
Since IH increases Nrf2 levels at variance with chronic hypoxia
[41], it is likely that IH generates an inhibition of prolyl-
hydroxylases that reveals sufficient to reduce nuclear
localization of CHOP and increase the expression of HO-1. The
oxidative stress associated with IH plays a role in the
development of increased cardiac ischemic tolerance. The
infarct size-limiting mechanism of IH seems to involve the PKC-
delta-dependent pathway but apparently not the increased
capacity of major antioxidant enzymes [42], and the
transcriptional activation of HSP70. Increased Nrf2 levels
seems to be crucial in the upregulation of HO-1, which has
been reported to have the most antioxidant response elements
on its promoter [43]. HO-1 activity also releases carbon
monoxide, which increases the expression of cardioprotective
and anti-apoptotic molecules [44].
A further consequence of decreased CHOP activation is the
relatively low oxidative stress that accompanies LAD in IH
compared to control hearts. Although the degree of protein
carbonylation might simply reflect the size of the infarcted area,
the possibility exists that the smaller size of the infarcts
observed in IH hearts derives from decreased oxidative stress.
Among its effects, CHOP positively regulates the expression of
the potent ER oxidase Ero1alpha, leading to oxidative stress
and apoptotic death [45]. It is therefore likely that the lower
number of cardiomyocytes displaying nuclear CHOP
localization in IH hearts represent a lesser source of oxidant
production when ischemia disrupts ER function, since nuclear
CHOP localization indicates the presence of a sustained ER-
stress response [45].
IH-induced signaling pathways
IH markedly activated Ser-473 Akt phosphorylation, which
was blunted on administration of wortmannin, concomitantly
with loss of IH-induced cardioprotection. This strongly suggests
that the cardioprotection elicited by IH is mediated by the
activation of the PI3K-Akt pathway. Hypoxia is not known as an
Akt activator, but the reoxygenation after hypoxia enables
cardiomyocytes to phosphorylate Akt [46] without affecting Akt
expression [47]. As the reoxygenation of hypoxic tissue is
associated to ROS bursts, ROS may act as triggers for Akt
phosphorylation [48,49]. The link among P-Akt, hypoxia and
cardioprotection is not universally acknowledged. In rats
exposed to IH (12% O2, 8 h/day for 4 and 8 weeks) P-Akt
decreases with increased apoptosis through both
mitochondrial-dependent and Fas death receptor-dependent
paths [50]. In cultured cardiomyocytes subjected to hypoxia
and reoxygenation, induction of gene 33 mRNA and Gene 33
protein reduces Akt signaling [51]. Both these examples refer
to IH situations that resemble the OSA-like rather than the
cardioprotective paradigm, which reinforces the idea that
cardioprotective IH is associated to enhanced PI3K-Akt
signaling. When IH is given for 4 h (40 s at 10% O2 followed by
20 s at 21% O2), the resulting cardioprotection, assessed in
Langendorff-perfused hearts, is largely due to the signaling
downstream PKC, p38 MAPK and ERK1/2 without involving the
PI3K signaling [52].
Several observations support a role for P-Akt to mediate
cardioprotection, in addition to its known effect in hypertensive
[53] and infarcted hearts [54]. A recognized factor that triggers
hypoxic preconditioning [55], its blockade by the antagonist
LY-294002 suppresses the cardioprotection induced by the
reoxygenation of hypoxic hearts [47]. The cascade activated by
Akt represents a common route in eliciting preconditioning, for
example by activating the endothelial isoform of NO synthase
[56] (see also Figure 4) and the NO/cGMP pathway, as
observed in hypoxic brain tissue [57]. The beneficial effect of
Akt activation on cardioprotection is evident in chronic
hypobaric IH (8 h/day, 25-30 exposures) [58]. The reactivation
of Akt has also been recognized as a critical determinant of
survival in post-hypoxic cardiomyocytes in culture [59]. By
contrast, in a minipig LAD model, the immunosuppressant
tacrolimus, or FK-506 or fujimycin, a 23-membered macrolide
lactone, was shown to limit infarct by suppressing the
inflammatory response through down-regulation of the Akt
signaling pathways [60], but the same substance also up-
regulates HO-1, which is at odds with our observations.
Interestingly, in an OSA model where IH is not protective, Akt
Ser473 phosphorylation was found to be decreased [61], in
agreement with present data. Akt activation may also provide
protection via increased eNOS and augmented NO stores. In
fact, the anti-hypertensive effect of IH in young spontaneously
hypertensive rats is associated with prevention of endothelial
dysfunction and with increased accumulation of NO stores in
vascular walls due to augmented eNOS activity [62]. The ability
of IH to increase eNOS is shared also in OSA-like models at
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the level of the carotid body [63]. Full understanding of the role
of NO in IH, however, should include monitoring not only of the
expression of Akt-activated eNOS, but also of transcriptionally-
activated iNOS, which has been shown to play a key role in IH-
induced delayed cardioprotection [64,65].
Conclusion
IH treatment may represent an efficient and economic way to
induce long-term preconditioning without use of drugs, and
comparable to the protection induced by physical training.
Here, we describe an IH protocol that enables hearts to
improve performance, induce neo-angiogenesis and resist to
I/R injury. We identified the PI3K-Akt signaling as a key path
that mediates IH-induced cardioprotection. Such pre-
conditioning would not necessarily reduce the incidence of
myocardial I/R injury, but would likely affect the severity of
myocardial damage.
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